http://www.inva.com
Innoviva, Inc. Company Intro
Innoviva leverages our own pharmaceutical industry expertise to provide financial management for life sciences companies, and solid investor returns.
Industry
Healthcare
Innoviva, Inc. Headquaters
1350 Old Bayshore Highway
Burlingame,94010
United States
Innoviva, Inc. Share price
20 Oct 2020 01:52 GMT
$10.00
0.06 (0.6 %)
Innoviva, Inc. Market cap
$997.697 M
WMC RANKING
2020
Innoviva, Inc. # 24
BiotechnologyLatest Innoviva, Inc. News
19 Oct 2020
Is a Correction Looming Ahead for Entasis Therapeutics ...
Innoviva, Inc., the 10% Owner of Entasis Therapeutics Holdings Inc., purchase 12,677,490 shares at $2.50 during a trade that took place back on Jun 11, which ...
19 Oct 2020
Is a Correction Looming Ahead for Entasis Therapeutics ...
Innoviva, Inc., the 10% Owner of Entasis Therapeutics Holdings Inc., purchase 12,677,490 shares at $2.50 during a trade that took place back on Jun 11, which ...
18 Oct 2020
Validea's Top Five Healthcare Stocks Based On David ...
INNOVIVA INC (INVA) is a small-cap value stock in the Biotechnology & Drugs industry. The rating according to our strategy based on David Dreman is 69% ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Innoviva, Inc. | 5.41 | 0 | 0 | 0 | 0 | 0 | 0 |
| Alexion Pharmaceuticals, Inc. | 100 | 11.92 | 100 | 0 | 0 | 0 | 100 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 3.66 | 0 | 0 | 0 | 92.62 |
| 3SBio Inc. | 96.05 | 0 | 0 | 0 | 0 | 0 | 0 |
| Incyte Corporation | 40.27 | 14.19 | 7.07 | 0 | 0 | 0 | 19.00 |
Innoviva, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Innoviva, Inc. | $299,350 | $13,012 | $228,039 | $997.697M | 24 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $26.687B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $57.436B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.572B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.193B | 4 |